AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionAtlantic Trust, LLC
Latest Disclosed Ownership13,538 shares
Latest Disclosed Value $ 2,944,313
Atlantic Trust, LLC reports 0.99% decrease in ownership of ABBV / AbbVie Inc.

On May 6, 2026 - Atlantic Trust, LLC filed a 13F-HR form disclosing ownership of 13,538 shares of AbbVie Inc. (US:ABBV) valued at $2,944,380 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 13,673 shares of AbbVie Inc.. This represents a change in shares of -0.99% during the quarter. The current value of the position is $2,939,506 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F ABBVIE COM 00287Y109 13,538 -135 -0.99 2,944 -5.76 0.4800
2026-02-09 2025-12-31 13F ABBVIE COM 00287Y109 13,673 -984 -6.71 3,124 -7.93 0.4918
2025-11-10 2025-09-30 13F ABBVIE COM 00287Y109 14,657 81 0.56 3,394 25.43 0.5798
2025-08-08 2025-06-30 13F ABBVIE COM 00287Y109 14,576 2,907 24.91 2,706 10.68 0.5119
2025-05-09 2025-03-31 13F AbbVie Com 00287Y109 11,669 -97 -0.82 2,445 16.94 0.5441
2025-02-10 2024-12-31 13F ABBVIE COM 00287Y109 11,766 -452 -3.70 2,091 -13.35 0.4519
2024-11-13 2024-09-30 13F ABBVIE COM 00287Y109 12,218 -551 -4.32 2,413 10.14 0.5776
2024-08-09 2024-06-30 13F ABBVIE COM 00287Y109 12,769 -1,320 -9.37 2,190 -14.62 0.5446
2024-05-10 2024-03-31 13F ABBVIE COM 00287Y109 14,089 -1,032 -6.82 2,566 9.48 0.6710
2024-02-06 2023-12-31 13F ABBVIE COM 00287Y109 15,121 -2,014 -11.75 2,343 -8.26 0.6407
2023-11-13 2023-09-30 13F ABBVIE COM 00287Y109 17,135 -22 -0.13 2,554 8.68 0.8401
2023-08-08 2023-06-30 13F AbbVie Com 00287Y109 17,157 576 3.47 2,351 -11.05 0.7548
2023-05-10 2023-03-31 13F AbbVie COM 00287Y109 16,581 -572 -3.33 2,643 132,000.00 0.8431
2023-02-01 2022-12-31 13F ABBVIE COM 00287Y109 17,153 379 2.26 3 -99.91 0.9241
2022-11-14 2022-09-30 13F ABBVIE COM 00287Y109 16,774 15,491 1,207.40 2,251 1,042.64 0.7833
2022-08-11 2022-06-30 13F AbbVie COM 00287Y109 1,283 0 0.00 197 -5.29 0.1498
2022-05-16 2022-03-31 13F AbbVie COM 00287Y109 1,283 -78 -5.73 208 13.04 0.1349
2022-02-09 2021-12-31 13F AbbVie Com 00287Y109 1,361 0 0.00 184 25.17 0.1086
2021-11-02 2021-09-30 13F AbbVie Com 00287Y109 1,361 617 82.93 147 75.00 0.0931
2021-08-12 2021-06-30 13F AbbVie Com 00287Y109 744 744 84 0.0548
2021-04-30 2021-03-31 13F AbbVie Com 00287Y109 0 -744 -100.00 0 -100.00
2021-02-16 2020-12-31 13F AbbVie Com 00287Y109 744 0 0.00 80 23.08 0.0476
2020-10-23 2020-09-30 13F AbbVie Com 00287Y109 744 0 0.00 65 -10.96 0.0516
2020-08-17 2020-06-30 13F AbbVie Com 00287Y109 744 0 0.00 73 28.07 0.0615
2020-05-12 2020-03-31 13F AbbVie Com 00287Y109 744 0 0.00 57 -13.64 0.0516
2020-02-03 2019-12-31 13F AbbVie Com 00287Y109 744 -56 -7.00 66 8.20 0.0484
2019-11-07 2019-09-30 13F AbbVie Com 00287Y109 800 0 0.00 61 5.17 0.0475
2019-07-31 2019-06-30 13F AbbVie Com 00287Y109 800 0 0.00 58 -10.77 0.0463
2019-05-13 2019-03-31 13F AbbVie Com 00287Y109 800 -1,192 -59.84 65 -64.67 0.0542
2019-02-13 2018-12-31 13F/A-1 AbbVie Com 00287Y109 1,992 0 0.00 184 -2.13 0.1711
2019-02-13 2018-12-31 13F AbbVie Com 00287Y109 1,992 184
2018-11-15 2018-09-30 13F AbbVie COM 00287Y109 1,992 -2,100 -51.32 188 -50.40 0.1442
2018-08-20 2018-06-30 13F AbbVie Com 00287Y109 4,092 1,992 94.86 379 90.45 0.3385
2018-05-15 2018-03-31 13F AbbVie COM 00287Y109 2,100 -367 -14.88 199 -16.74 0.1708
2018-02-14 2017-12-31 13F AbbVie Com 00287Y109 2,467 0 0.00 239 9.13 0.1634
2017-11-17 2017-09-30 13F AbbVie Com 00287Y109 2,467 0 0.00 219 22.35 0.1629
2017-08-21 2017-06-30 13F AbbVie Com 00287Y109 2,467 1,667 208.38 179 244.23 0.1413
2017-06-19 2017-03-31 13F AbbVie COM 00287Y109 800 0 0.00 52 4.00 0.0430
2017-06-14 2016-12-31 13F AbbVie COM 00287Y109 800 800 50 0.0449
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.